CD Biosynsis provides a professional Phaeodactylum tricornutum Gene Knockout Platform, specifically designed to address the sophisticated requirements of marine synthetic biology and diatom research. Phaeodactylum tricornutum is recognized as a premier model pennate diatom due to its well-annotated genome, rapid growth characteristics, and its significant role in global carbon cycling and marine ecology. Our platform leverages the latest advancements in CRISPR-Cas9 and Cas12a (Cpf1) technologies to achieve precise, permanent, and biallelic disruption of target genomic loci, overcoming the traditional challenges associated with the diploid nature of this organism.
Beyond simple gene silencing, our knockout services provide a definitive foundation for complex metabolic engineering. By utilizing DNA-free Ribonucleoprotein (RNP) delivery or highly stable episomal systems, we enable the creation of clean, marker-free mutant backgrounds. This is particularly crucial for industrial applications where the presence of foreign DNA or antibiotic resistance genes is restricted. Our services encompass the entire development cycle, from the initial bioinformatic assessment of gene redundancy and gRNA window optimization to high-throughput monoclonal isolation. We ensure that every knockout strain is characterized by genetic stability and phenotypic consistency, providing researchers with a robust chassis for the production of high-value bioproducts like EPA, fucoxanthin, and specialized biofuels.
Get a QuoteGene knockout in Phaeodactylum tricornutum is a transformative tool for uncovering the unique evolutionary history and biological mechanisms of diatoms. Unlike traditional knockdown methods such as RNA interference (RNAi), which often result in incomplete protein suppression or transient phenotypes, our CRISPR-mediated knockout service delivers permanent, biallelic disruption at the DNA level. This absolute loss-of-function is essential for accurately mapping metabolic bottlenecks and redirecting carbon flux away from primary biomass toward secondary metabolites.
Our platform is meticulously optimized to handle the high GC-content and specific codon bias of the P. tricornutum nucleus, ensuring that the CRISPR machinery is expressed at levels sufficient for high-efficiency editing. We specialize in advanced modifications, including large fragment deletions reaching up to 2.7 kb and multiplexed knockouts that can target several members of a gene family simultaneously. This capability is vital for bypassing genetic redundancy, which is frequently encountered in the diatom genome. By delivering a highly defined and verified genotype, we allow our clients to achieve predictable phenotypic outcomes and significantly reduce the time required for target validation in marine biotechnology.
To maximize the success rate across diverse genetic targets, we offer multiple specialized knockout strategies tailored to the unique physiological and genomic landscape of Phaeodactylum tricornutum.
Simultaneous Targeting
Simultaneous delivery of multiple gRNAs to target up to six distinct sites or gene family members, allowing for the ablation of entire redundant pathways in a single transformation.
Glycosylation Engineering
Efficient knockout of multigene families, such as the fucosyltransferase (FucT) family, to humanize algal protein glycosylation for the synthesis of complex biopharmaceuticals.
Transient Precision
Utilizing pre-assembled Cas9-gRNA RNP complexes to achieve high transient activity. This method leaves no "genomic scar" and avoids the integration of foreign DNA into the host genome.
Off-Target Mitigation
By limiting the duration of Cas9 presence in the cell, RNP delivery significantly reduces the cumulative risk of off-target mutations compared to stable plasmid expression.
Metabolic Chassis
Precise knockout of essential biosynthetic pathways (e.g., uracil or histidine) to create auxotrophic strains that serve as robust platforms for subsequent marker-free genetic work.
Our systematic technical pipeline is designed to ensure the delivery of high-quality, monoclonal knockout strains with full genomic transparency.
1. Bioinformatic Design
2. Tool Construction
3. Transformation & Screening
4. Genotyping & Delivery
Utilizing the latest diatom genomic databases to identify target loci and perform off-target predictive analysis. We design high-specificity gRNAs and optimize nuclease codon bias for the P. tricornutum nuclear environment.
Synthesis of high-purity RNP complexes or construction of diatom-specific episomal vectors. For multiplexed projects, we integrate Csy4 processing or poly-cistronic arrays to ensure balanced gRNA expression.
Verification: Confirmation of indels or deletions via Sanger/NGS sequencing and TIDE analysis. Functional assessment of the knockout phenotype. Delivery of cryopreserved strains and detailed reports.
Biallelic Precision
We guarantee the disruption of all alleles in the diploid diatom host, providing a stable loss-of-function background for definitive research results.
Multiplex Expertise
Ability to disrupt entire gene families in a single step, saving months of research time compared to sequential knockout methods.
Industrial Stability
All delivered strains are verified for genetic stability over dozens of passages, ensuring they perform consistently in large-scale cultivation environments.
Comprehensive Verification
We utilize Next-Generation Sequencing (NGS) to verify the precise genomic modification and ensure no wild-type contamination remains.
1. How do you confirm the biallelic knockout in Phaeodactylum tricornutum?
We perform locus-specific PCR followed by Sanger or NGS sequencing. By analyzing the sequence traces using tools like TIDE or ICE, we can quantify the ratio of indels to wild-type sequences and confirm that no wild-type alleles remain.
2. What is the benefit of large fragment deletions?
Large deletions are more robust for achieving complete loss-of-function and are significantly easier to screen via standard PCR. They also prevent the possibility of alternative start sites or partially functional truncated proteins.
3. Are the final knockout strains marker-free?
If DNA-free RNP delivery is used, the strains are inherently marker-free. For episomal delivery, we can utilize vector curing strategies to remove the selection marker after the edit has been confirmed.
4. Can you perform knockouts in the chloroplast genome of Phaeodactylum?
Yes, we offer specialized chloroplast engineering protocols utilizing biolistic bombardment to target the polyploid chloroplast genome for photosynthetic research.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.